Czrina Cortez

Sorbonne Université — France

Immunology and Microbiology · Life Sciences

9h-index1.4kcitations55works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(26), Cancer Immunotherapy and Biomarkers(14), Immune Cell Function and Interaction(12), Immunotherapy and Immune Responses(11), Cancer Research and Treatments(10)

Publications55 total

Photoinduced thermal strain in epitaxial <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msub><mml:mi>SrRuO</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:math> thin films
Physical Review Materials·2025
Figure S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S4 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S5 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Data from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S3 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S4 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S4 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S1 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Data from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Table S5 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
Figure S2 from Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Jedd D. Wolchok(25), Betty Li(20), Carmence Ho(20), Amir M. Ashique(20), Vicky Y. Lin(20), Julie M. Roda(20), Bin Fan(20), James Sissons(20), Jonathan Sitrin(20), Don L. Gibbons(20), Lee B. Rivera(20), Katherine S. Panageas(19), B. Leticia Rodriguez(19), Jiawei Huang(19), Laura Gibson(19), Jared J. Fradette(19), Hung-I Harry Chen(19), Kikuye Koyano(19), Suzanne Crawley(19), Peirong Chen(19)